{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:10Z","timestamp":1790629750141,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"\u00d6rebro County Council Research Committee"},{"name":"Foundation for Medical Research at \u00d6rebro University Hospital"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Treatment of gonorrhoea is a challenge worldwide because of emergence of resistance in <jats:italic>N<\/jats:italic>. <jats:italic>gonorrhoeae<\/jats:italic> to all therapeutic antimicrobials available and novel antimicrobials are imperative. The newer\u2010generation fluoroquinolone sitafloxacin, mostly used for respiratory tract infections in Japan, can have a high <jats:italic>in vitro<\/jats:italic> activity against gonococci. However, only a limited number of recent antimicrobial\u2010resistant isolates from Japan have been examined. We investigated the sitafloxacin activity against a global gonococcal panel (250 isolates cultured in 1991\u20132013), including multidrug\u2010resistant geographically, temporally and genetically diverse isolates, and performed time\u2010kill curve analysis for sitafloxacin. The susceptibility to sitafloxacin (agar dilution) and seven additional therapeutic antimicrobials (Etest) was determined. Sitafloxacin was rapidly bactericidal, and the <jats:styled-content style=\"fixed-case\">MIC<\/jats:styled-content> range, <jats:styled-content style=\"fixed-case\">MIC<\/jats:styled-content><jats:sub>50<\/jats:sub> and <jats:styled-content style=\"fixed-case\">MIC<\/jats:styled-content><jats:sub>90<\/jats:sub> was \u22640.001\u20131, 0.125 and 0.25 mg\/L, respectively. There was a high correlation between the <jats:styled-content style=\"fixed-case\">MIC<\/jats:styled-content>s of sitafloxacin and ciprofloxacin; however, the <jats:styled-content style=\"fixed-case\">MIC<\/jats:styled-content><jats:sub>50<\/jats:sub> and <jats:styled-content style=\"fixed-case\">MIC<\/jats:styled-content><jats:sub>90<\/jats:sub> of sitafloxacin were 6\u2010fold and &gt;6\u2010fold lower, respectively. Sitafloxacin might be an option for particularly dual antimicrobial therapy of gonorrhoea and for cases with ceftriaxone resistance or allergy. However, further <jats:italic>in vitro<\/jats:italic> and particularly <jats:italic>in vivo<\/jats:italic> evaluations of potential resistance, pharmacokinetics\/pharmacodynamics and ideal dosing for gonorrhoea, as well as performance of randomized controlled clinical, trials are crucial.<\/jats:p>","DOI":"10.1111\/apm.12777","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T13:26:37Z","timestamp":1511184397000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["<i>In vitro<\/i> activity and time\u2010kill curve analysis of sitafloxacin against a global panel of antimicrobial\u2010resistant and multidrug\u2010resistant <i>Neisseria gonorrhoeae<\/i> isolates"],"prefix":"10.1111","volume":"126","author":[{"given":"Agnez","family":"J\u00f6nsson","sequence":"first","affiliation":[{"name":"WHO Collaborating Centre for Gonorrhoea and other STIs Department of Laboratory Medicine, Microbiology Faculty of Medicine and Health \u00d6rebro University \u00d6rebro Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunniva","family":"Foerster","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Gonorrhoea and other STIs Department of Laboratory Medicine, Microbiology Faculty of Medicine and Health \u00d6rebro University \u00d6rebro Sweden"},{"name":"Institute for Infectious Diseases University of Bern Bern Switzerland"},{"name":"Institute of Social and Preventive Medicine University of Bern Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Gonorrhoea and other STIs Department of Laboratory Medicine, Microbiology Faculty of Medicine and Health \u00d6rebro University \u00d6rebro Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Hamasuna","sequence":"additional","affiliation":[{"name":"Department of Urology School of Medicine University of Occupational and Environmental Health Kitakyushu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Jacobsson","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Gonorrhoea and other STIs Department of Laboratory Medicine, Microbiology Faculty of Medicine and Health \u00d6rebro University \u00d6rebro Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Lindberg","sequence":"additional","affiliation":[{"name":"Department of Dermatovenerology \u00d6rebro University Hospital \u00d6rebro Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rgen Skov","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infection Control, Sexually Transmitted Infections, Research and Development Statens Serum Institut Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Bacteriology I National Institute of Infectious Diseases Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Gonorrhoea and other STIs Department of Laboratory Medicine, Microbiology Faculty of Medicine and Health \u00d6rebro University \u00d6rebro Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143304"},{"key":"e_1_2_6_3_1","unstructured":"World Health Organization (WHO).Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae.2012.http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503501_eng.pdf?ua=1"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00010-14"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.268"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1029-2"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks162"},{"key":"e_1_2_6_10_1","first-page":"85","article-title":"European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"2013","author":"Bignell C","year":"2012","journal-title":"Int J STD AIDS"},{"key":"e_1_2_6_11_1","unstructured":"Australasian Sexual Health Alliance (ASHA).Australian STI Management Guidelines for Use in Primary Care.www.sti.guidelines.org.au\/sexually-transmissible-infections\/gonorrhoea#management(Last updated: 27 June 2016)."},{"key":"e_1_2_6_12_1","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski KA","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_6_13_1","unstructured":"Public Health Agency of Canada.Canadian Guidelines on Sexually Transmitted Infections. Gonococcal Infections Chapter. 2013.www.phac-aspc.gc.ca\/std-mts\/sti-its\/cgsti-ldcits\/assets\/pdf\/section-5-6-eng.pdf"},{"key":"e_1_2_6_14_1","unstructured":"World Health Organization Department of Reproductive Health and Research.WHO Guidelines for the Treatment of Neisseria gonorrhoeae.2016.http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27512795."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1512757"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/11207380-000000000-00000"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-013-0637-2"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jiac.2015.01.010","article-title":"The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012\u20132013","volume":"21","author":"Hamasuna R","year":"2015","journal-title":"J Infect Chemother"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/39.2.247","article-title":"Antimicrobial activity of a new fluoroquinolone, DU\u20106859a, against quinolone\u2010resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV","volume":"39","author":"Deguchi T","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.44.1.192-195.2000","article-title":"Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics","volume":"44","author":"Tanaka M","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.1102-1107.2000"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.63"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp098"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw288"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JCM.40.10.3741-3749.2002","article-title":"Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains","volume":"40","author":"Unemo M","year":"2002","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_26_1","unstructured":"Clinical and Laboratory Standards Institute.2014 Performance standards for antimicrobial susceptability testing; 25th informational supplement. CLSI document M100\u2010S24.Wayne PA:Clinical and Laboratory Standards Institute 2014; Available at:http:\/\/clsi.org Accessed 01\/13 2017."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-016-0838-9"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3389\/fmicb.2015.01377","article-title":"Genetic resistance determinants, in vitro time\u2010kill curve analysis and pharmacodynamic functions for the novel topoisomerase II inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae","volume":"6","author":"Foerster S","year":"2015","journal-title":"Front Microbiol"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2007.00776.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7012(03)00194-5"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03090-14"},{"issue":"1","key":"e_1_2_6_32_1","first-page":"146","article-title":"Clinical study of sitafloxacin in the treatment of male gonococcal urethritis","volume":"56","author":"Onodera S","year":"2008","journal-title":"Jpn J Chemother"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02246.x"},{"key":"e_1_2_6_34_1","unstructured":"HoriS KobayashiH SaitoA.Clinical trials of sitafloxacin (DU\u20106859a): clinical safety profile [abstract no. L\u2010489 plus poster]. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy;2007Sep 17\u201020;Chicago (IL)."},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.1.170"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/0049825011"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2016.12.010"},{"key":"e_1_2_6_38_1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.5414\/CP202147","article-title":"Pharmacokinetics and safety of sitafloxacin after single oral doses in healthy volunteers","volume":"52","author":"Wu G","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0392-9"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-013-0620-y"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapm.12777","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.12777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T20:56:04Z","timestamp":1696020964000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apm.12777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/apm.12777"],"URL":"https:\/\/doi.org\/10.1111\/apm.12777","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]},"assertion":[{"value":"2017-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}